08:02 AM EDT, 10/03/2025 (MT Newswires) -- Alto Neuroscience ( ANRO ) said Friday it has been granted fast-track designation for ALTO-101 for the treatment of cognitive impairment associated with schizophrenia by the US Food and Drug Administration. Phase 1 data for the treatment showed significant and clinically relevant effects on both electroencephalogram measures and cognitive performance in healthy subjects...

07:59 AM EDT, 10/03/2025 (MT Newswires) -- Alphabet's (GOOG, GOOGL) YouTube ( GOOG ) said a channel containing hundreds of artificial intelligence-generated Bollywood videos has been deleted by its creator and the content is no longer available on the platform, Reuters reported Friday, citing an email from the company. The channel was taken down after Reuters reported that it showed...

08:01 AM EDT, 10/03/2025 (MT Newswires) -- UBS said it expects the Reserve Bank of New Zealand to deliver a 50bps cut at Wednesday's policy meeting after a significantly weaker-than-expected gross domestic prodcut print, more balanced inflation risks and only tentative signs of a recovery into 2026. The RBNZ had already turned dovish in August prior to the GDP data,...

07:59 AM EDT, 10/03/2025 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Friday it voluntarily withdrew its biologics license application to the US Food and Drug Administration for its investigational mozafancogene autotemcel treatment of Fanconi anemia, a rare inherited disorder. The withdrawal is mainly due to business reasons and not because of any safety or efficacy concerns, with data...